A DISCUSSION OF THE TERM “METABOLITE”, AS CONTAINED IN THE STATUTORY DEFINITION OF A DIETARY INGREDIENT

 

March 25, 2003

 

Draft Agenda

 

 

  8:00-  8:05     Welcome/Member Introduction  Johanna Dwyer, Ph.D., Chairman Christine L. Taylor, Ph.D., FDA

 

 

  8:05-  8:35     Administrative Issues – Mary Ann Killian and Constance J. Hardy, FDA

 

  8:35-  9:05     Charge and Questions; “Defining Dietary Supplement Ingredients”, Regulatory Perspective and Challenges

Christine L. Taylor, Ph.D., FDA and Robert J. Moore, Ph.D., FDA

 

  9:05-  9:2515     Remarks by Chairperson, Johanna Dwyer, D.Sc., R.D.

 

  9:2515-9:4510:00     Break“Biochemical Facts Behind the Definition and Properties of Metabolites”,  Edward D. Harris, Ph.D.

  9:45- 10:30                      “Biochemical Facts Behind the Definition and Properties of Metabolites”,  Edward D. Harris, Ph.D.

10:00-10:15            Break

 

10:3015-11:30       Questions and Discussion  by Subcommittee Members on Edward Harris’s presentation

 

11:30-12:30    Lunch           

 

12:30-  1:30    Public Comment

 

  1:30-  3:00    Discussion of Charge and Questions by Subcommittee 

             

  3:00-  3:15            Break

 

  3:15-  4:50     Continuation of Charge/Questions; Recommendations by Subcommittee

 

  4:50-  5:00     Concluding Remarks